Adherium Limited Stock

Equities

ADR

AU000000ADR1

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:27:46 2024-05-01 EDT 5-day change 1st Jan Change
0.02 AUD -9.09% Intraday chart for Adherium Limited -16.67% -64.29%

Financials

Sales 2022 529K 345K 474K Sales 2023 3.2M 2.09M 2.86M Capitalization 12.5M 8.16M 11.2M
Net income 2022 -10M -6.53M -8.96M Net income 2023 -9M -5.88M -8.07M EV / Sales 2022 19.4 x
Net cash position 2022 5.2M 3.39M 4.66M Net cash position 2023 9.03M 5.9M 8.1M EV / Sales 2023 1.08 x
P/E ratio 2022
-1.4 x
P/E ratio 2023
-1.04 x
Employees 40
Yield 2022 *
-
Yield 2023
-
Free-Float 69.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day-9.09%
1 week-16.67%
Current month-52.38%
1 month-53.49%
3 months-55.56%
6 months-55.56%
Current year-64.29%
More quotes
1 week
0.02
Extreme 0.019
0.02
1 month
0.02
Extreme 0.019
0.09
Current year
0.02
Extreme 0.019
0.09
1 year
0.02
Extreme 0.019
0.09
3 years
0.02
Extreme 0.019
0.45
5 years
0.02
Extreme 0.019
0.96
10 years
0.02
Extreme 0.019
10.80
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 22-10-09
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 20-08-02
Members of the board TitleAgeSince
Director/Board Member 75 15-04-16
Director/Board Member 61 15-12-16
Director/Board Member 66 15-07-19
More insiders
Date Price Change Volume
24-05-01 0.02 -9.09% 2,396,358
24-04-30 0.022 0.00% 949,555
24-04-29 0.022 -8.33% 2,035,467
24-04-26 0.024 -17.24% 4,599,885

Delayed Quote Australian S.E., May 01, 2024 at 01:27 am

More quotes
Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.
More about the company

Annual profits - Rate of surprise